| Not Yet Recruiting | Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-s Tuberculosis, Multidrug-Resistant | — | 2024-11-30 |
| Unknown | Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab. Acute Gastritis, Chronic Gastritis | — | 2021-10-07 |
| Completed | A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis Acute Gastritis, Chronic Gastritis | Phase 3 | 2019-12-30 |
| Completed | To Evaluate Food Effect on the Pharmacokinetics of Rebamipide in Healthy Volunteers Healthy Volunteers | Phase 1 | 2019-07-05 |
| Completed | Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Auto Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Phase 4 | 2019-07-01 |
| Completed | To Evaluate Pharmacokinetics and Safety of Two Different Formulation of Rebamipide in Healthy Volunteers Healthy Volunteers | Phase 1 | 2019-04-22 |
| Unknown | Iclusig PMS in CML or Ph+ALL Patients Chronic Myeloid Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia | — | 2018-08-07 |
| Recruiting | A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression Depression, Bipolar | Phase 3 | 2018-02-22 |
| Completed | MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipi Schizophrenia, Antipsychotics, Long-Acting Injection | Phase 4 | 2017-11-21 |
| Completed | Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With M Multi-drug Resistant Tuberculosis | — | 2017-05-25 |
| Completed | Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder Schizophrenia, Bipolar 1 Disorder | — | 2016-12-13 |
| Completed | Samsca PMS in ADPKD Patients Safety | — | 2016-07-19 |
| Completed | Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor Solid Tumor | Phase 1 | 2014-10-23 |
| Completed | Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina Vasospastic Angina | Phase 3 | 2013-12-01 |
| Completed | A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospasti Vasospastic Angina | Phase 3 | 2013-11-01 |
| Completed | OPS-2071 Single and Multiple Dose Study to Investigate PK and PD Profile in Healthy Korean Male Subjects. Healthy | Phase 1 | 2013-08-01 |
| Completed | Samsca Post Marketing Surveillance Study Hypervolemic and Euvolemic Hyponatremia | — | 2013-07-09 |
| Terminated | A Phase I, Open Label, Non Randomized, Multicenter, Dose Escalation Clinical Study to Investigate Safety and T Advanced Hepatocellular Carcinoma | Phase 1 | 2013-05-29 |
| Completed | Pletaal SR Post Marketing Observational Study Ischemic Symptoms, Cerebral Infarction | — | 2013-01-01 |
| Terminated | Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart Failure Heart Failure With Hyponatremia | Phase 4 | 2012-12-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of Pletaal SR Capsule (Cilostazol) in Subjects With Peripheral Art Chronic Occlusive Arterial Disease | Phase 4 | 2012-10-26 |
| Completed | Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy Diabetic Nephropathy | Phase 2 | 2012-10-01 |
| Completed | ABF Tourette's Disorder Post Marketing Surveillance Study Tourette's Disorder | — | 2012-06-01 |
| Terminated | Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With Ascites Hyponatremia and Extracellular Fluid in Cirrhotic | Phase 4 | 2012-04-01 |
| Completed | Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina Variant Angina | Phase 2 | 2011-10-01 |
| Completed | Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Sa Peripheral Artery Disease | Phase 2 | 2010-05-19 |
| Completed | Open-label, Extension Study of CDP870 in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 3 | 2010-03-01 |
| Completed | Pharmacokinetics/Pharmacodynamics (PK/PD) Characteristics of Tolvaptan Tablet in Korean Healthy Male Healthy | Phase 1 | 2010-01-01 |
| Completed | A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 3 | 2009-10-01 |
| Completed | Pharmacokinetics Study for Probucol Healthy | Phase 4 | 2009-02-01 |
| Completed | Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder Chronic Motor or Vocal Tic Disorder, Tourette's Disorder | Phase 3 | 2008-10-01 |
| Unknown | An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors Solid Tumor | Phase 1 | 2008-03-01 |
| Completed | PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity Rheumatoid Arthritis, Osteoarthritis, Ankylosing Spondylitis | Phase 3 | 2007-12-01 |
| Completed | Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness Bipolar Disorder | Phase 4 | 2007-12-01 |
| Completed | Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness Bipolar Disorder | Phase 4 | 2007-10-01 |
| Unknown | Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients Oral Mucositis | — | 2007-10-01 |
| Completed | Safety and Pharmacokinetics of Probucol and Cilostazol Healthy | Phase 4 | 2007-10-01 |
| Completed | Cilostazol in Acute Ischemic Stroke Treatment (CAIST) Cerebral Infarction | Phase 4 | 2006-01-01 |
| Completed | SWitching to Abilify Trial (SWAT) Schizophrenia | Phase 4 | 2004-10-01 |
| Completed | Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS) Schizophrenia, Schizoaffective Disorder | Phase 4 | 2004-07-01 |
| Completed | Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder Schizophrenia, Bipolar Disorder | — | 2004-04-01 |
| Completed | Efficacy and Safety of Cilostazol for the Indication of CSPS Cerebral Infarction | — | 2003-12-01 |